92 related articles for article (PubMed ID: 16307562)
1. Activity of five quinolones, three macrolides and telithromycin against 12 Haemophilus influenzae strains with different resistance phenotypes.
Pankuch GA; Lin G; Appelbaum PC
Clin Microbiol Infect; 2005 Dec; 11(12):1040-4. PubMed ID: 16307562
[TBL] [Abstract][Full Text] [Related]
2. Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
Kosowska K; Credito K; Pankuch GA; Hoellman D; Lin G; Clark C; Dewasse B; McGhee P; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2004 Nov; 48(11):4113-9. PubMed ID: 15504829
[TBL] [Abstract][Full Text] [Related]
3. Activity of LBM415 compared to those of 11 other agents against Haemophilus species.
Bogdanovich T; Smith KA; Clark C; Pankuch GA; Lin G; McGhee P; Dewasse B; Appelbaum PC
Antimicrob Agents Chemother; 2006 Jul; 50(7):2323-9. PubMed ID: 16801408
[TBL] [Abstract][Full Text] [Related]
4. Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae.
Bogdanovich T; Bozdogan B; Appelbaum PC
Antimicrob Agents Chemother; 2006 Mar; 50(3):893-8. PubMed ID: 16495248
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
Walsh F; Carnegy F; Willcock J; Amyes S
J Antimicrob Chemother; 2004 May; 53(5):793-6. PubMed ID: 15056640
[TBL] [Abstract][Full Text] [Related]
6. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
Bogdanovich T; Clark C; Ednie L; Lin G; Smith K; Shapiro S; Appelbaum PC
Antimicrob Agents Chemother; 2006 Jun; 50(6):2050-7. PubMed ID: 16723565
[TBL] [Abstract][Full Text] [Related]
7. Selection of resistance of telithromycin against Haemophilus influenzae, Moraxella catarrhalis and streptococci in comparison with macrolides.
Drago L; De Vecchi E; Nicola L; Colombo A; Gismondo MR
J Antimicrob Chemother; 2004 Aug; 54(2):542-5. PubMed ID: 15215227
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro and bactericidal activities of telithromycin against penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant Streptococcus pneumoniae by time-kill methodology.
Kays MB; Lisek CR; Denys GA
Int J Antimicrob Agents; 2007 Mar; 29(3):289-94. PubMed ID: 17240118
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrations.
De Vecchi E; Nicola L; Larosa M; Drago L
BMC Microbiol; 2008 Jan; 8():23. PubMed ID: 18230154
[TBL] [Abstract][Full Text] [Related]
10. Kinetic bactericidal activity of telithromycin, azithromycin and clarithromycin against respiratory pathogens.
Drago L; De Vecchi E; Nicola L; Legnani D; Gismondo MR
APMIS; 2005 Oct; 113(10):655-63. PubMed ID: 16309423
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of telithromycin against respiratory tract pathogens in comparison with other antimicrobial agents.
Ling TK; Lee CC
Chemotherapy; 2005 Jul; 51(4):182-5. PubMed ID: 15980628
[TBL] [Abstract][Full Text] [Related]
12. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
Mazzariol A; Koncan R; Vitali LA; Cornaglia G
J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
[TBL] [Abstract][Full Text] [Related]
13. Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.
Kosowska-Shick K; Credito K; Pankuch GA; Lin G; Bozdogan B; McGhee P; Dewasse B; Choi DR; Ryu JM; Appelbaum PC
Antimicrob Agents Chemother; 2006 Jun; 50(6):2064-71. PubMed ID: 16723567
[TBL] [Abstract][Full Text] [Related]
14. [in vitro activity of telithromycin against Haemophilus influenzae].
Dabernat H; Seguy M; Delmas C
Pathol Biol (Paris); 2002 Feb; 50(1):58-62. PubMed ID: 11873632
[TBL] [Abstract][Full Text] [Related]
15. Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing.
Stout JE; Sens K; Mietzner S; Obman A; Yu VL
Int J Antimicrob Agents; 2005 Apr; 25(4):302-7. PubMed ID: 15784309
[TBL] [Abstract][Full Text] [Related]
16. Time-kill study of the activity of telithromycin against macrolide-resistant Streptococcus pneumoniae Isolates with 23S rRNA mutations and changes in ribosomal proteins L4 and L22.
Reinert RR; Al-Lahham A
Antimicrob Agents Chemother; 2005 Jul; 49(7):3011-3. PubMed ID: 15980387
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics of telithromycin In vitro against respiratory tract pathogens.
Odenholt I; Löwdin E; Cars O
Antimicrob Agents Chemother; 2001 Jan; 45(1):23-9. PubMed ID: 11120939
[TBL] [Abstract][Full Text] [Related]
18. Influence of variations in test methods on susceptibility of Haemophilus influenzae to ampicillin, azithromycin, clarithromycin, and telithromycin.
Fuchs PC; Barry AL; Brown SD
J Clin Microbiol; 2001 Jan; 39(1):43-6. PubMed ID: 11136745
[TBL] [Abstract][Full Text] [Related]
19. Activity of HMR 3647 compared to those of five agents against Haemophilus influenzae and moraxella catarrhalis by MIC determination and time-kill assay.
Pankuch GA; Hoellman DB; Lin G; Bajaksouzian S; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1998 Nov; 42(11):3032-4. PubMed ID: 9797250
[TBL] [Abstract][Full Text] [Related]
20. Activity of telithromycin against 26 quinolone-resistant pneumococci with known quinolone-resistance mechanisms.
Nagai K; Hoellman D; Davies T; Jacobs M; Appelbaum P
Clin Microbiol Infect; 2001 Dec; 7(12):703-5. PubMed ID: 11843916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]